Status:
UNKNOWN
Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma
Lead Sponsor:
China Medical University Hospital
Conditions:
Lung Adenocarcinoma
Eligibility:
All Genders
25-85 years
Brief Summary
Optic atrophy type 1(OPA1) is a nuclear dynamin-related GTPase, targeted to the inner mitochondrial membrane, which plays a role in mitochondrial fusion. Mitochondria fusion is associated with process...
Eligibility Criteria
Inclusion
- We will collect paraffin blocked resected lung tissue samples from stage I\~IIIa non-small cell lung cancer patients (age, 40\~80 years old) who received lobectomy of the affected lung.
Exclusion
- History of uremia, other malignant disease, and liver cirrhosis
- History of pneumonia and pulmonary tuberculosis
- History of long period of medications.
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01249053
Start Date
August 1 2010
Last Update
November 29 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fang Hsin Yuan
Taichung, Taiwan, 404